AIM: To assess hepatic fibrosis and factors associated with its progression in children with HCV infection. METHODS: At the Hepatology Unit, Cairo University Children's Hospital, a single liver biopsy was performed to 43 children with HCV infection after an informed consent between 1998-2004. Their mean age at liver biopsy was 8.67 +/- 4.3 years. RESULTS: Among the 43 patients' biopsies, 12 (27.9%) were having no fibrosis, 20 (46.5%) mild fibrosis and 11 (25.6%) moderate to severe fibrosis. The median time for development of fibrosis was estimated to be 5.5 years. Developing fibrosis was significantly associated with shorter duration from first detected ALT elevation to biopsy (12 mo vs 1.2 mo, P=0.015) and having higher levels of direct serum bilirubin (0.3 mg/dL vs 0.5 mg/dL, P=0.048). No association was found between fibrosis stage and the presence of co-morbid conditions (P=0.33). CONCLUSION: Hepatic fibrosis was present in 72.1% of children with HCV infection. The development of fibrosis was associated with higher levels of direct serum bilirubin. There was no significant association between fibrosis and age, duration of infection, risk factors, co-morbid conditions and most biochemical parameters.
AIM: To assess hepatic fibrosis and factors associated with its progression in children with HCV infection. METHODS: At the Hepatology Unit, Cairo University Children's Hospital, a single liver biopsy was performed to 43 children with HCV infection after an informed consent between 1998-2004. Their mean age at liver biopsy was 8.67 +/- 4.3 years. RESULTS: Among the 43 patients' biopsies, 12 (27.9%) were having no fibrosis, 20 (46.5%) mild fibrosis and 11 (25.6%) moderate to severe fibrosis. The median time for development of fibrosis was estimated to be 5.5 years. Developing fibrosis was significantly associated with shorter duration from first detected ALT elevation to biopsy (12 mo vs 1.2 mo, P=0.015) and having higher levels of direct serum bilirubin (0.3 mg/dL vs 0.5 mg/dL, P=0.048). No association was found between fibrosis stage and the presence of co-morbid conditions (P=0.33). CONCLUSION:Hepatic fibrosis was present in 72.1% of children with HCV infection. The development of fibrosis was associated with higher levels of direct serum bilirubin. There was no significant association between fibrosis and age, duration of infection, risk factors, co-morbid conditions and most biochemical parameters.
Authors: M Prieto; M Berenguer; J M Rayón; J Córdoba; L Argüello; D Carrasco; A García-Herola; V Olaso; M De Juan; M Gobernado; J Mir; J Berenguer Journal: Hepatology Date: 1999-01 Impact factor: 17.425
Authors: M Kage; T Fujisawa; K Shiraki; T Tanaka; T Fujisawa; A Kimura; K Shimamatsu; E Nakashima; M Kojiro; M Koike; Y Tazawa; D Abukawa; M Okaniwa; H Takita; A Matsui; T Hayashi; T Etou; S Terasawa; K Sugiyama; H Tajiri; A Yoden; Y Kajiwara; M Sata; Y Uchimura Journal: Hepatology Date: 1997-09 Impact factor: 17.425
Authors: M Vogt; T Lang; G Frösner; C Klingler; A F Sendl; A Zeller; B Wiebecke; B Langer; H Meisner; J Hess Journal: N Engl J Med Date: 1999-09-16 Impact factor: 91.245
Authors: P Mathurin; J Moussalli; J F Cadranel; V Thibault; F Charlotte; P Dumouchel; A Cazier; J M Huraux; B Devergie; M Vidaud; P Opolon; T Poynard Journal: Hepatology Date: 1998-03 Impact factor: 17.425
Authors: M S El-Raziky; M El-Hawary; N El-Koofy; S Okasha; M Kotb; K Salama; G Esmat; M El-Raziky; A M Abouzied; H El-Karaksy Journal: J Viral Hepat Date: 2004-09 Impact factor: 3.728
Authors: Elizabeth M Brunt; Sunil Ramrakhiani; Barry G Cordes; Brent A Neuschwander-Tetri; Christine G Janney; Bruce R Bacon; Adrian M Di Bisceglie Journal: Mod Pathol Date: 2003-01 Impact factor: 7.842
Authors: Päivi Halonen; Jorma Mattila; Pauli Suominen; Tarja Ruuska; Matti K Salo; Anne Mäkipernaa Journal: Pediatrics Date: 2003-01 Impact factor: 7.124
Authors: Mark Danta; Gregory J Dore; Lisa Hennessy; Yueming Li; Chris R Vickers; Hugh Harley; Meng Ngu; William Reed; Paul V Desmond; William Sievert; Geoff C Farrell; John M Kaldor; Robert G Batey Journal: Med J Aust Date: 2002-09-02 Impact factor: 7.738
Authors: Philip Rosenthal; Kathleen B Schwarz; Regino P Gonzalez-Peralta; Chuan-Hao Lin; Deidre A Kelly; Scott Nightingale; William F Balistreri; Sanjay Bansal; Maureen M Jonas; Benedetta Massetto; Diana M Brainard; Chia-Hsiang Hsueh; Jiang Shao; Bandita Parhy; Suzanne Davison; Cornelia Feiterna-Sperling; Lynette A Gillis; Giuseppe Indolfi; Etienne M Sokal; Karen F Murray; Stefan Wirth Journal: Hepatology Date: 2019-08-13 Impact factor: 17.425